The abstract is read at the publisher; the summary is JClub's.
Nationwide functional profiling of 303 KCNH2 variants in the French LQT2 population reclassified 64 of 201 VUS (31.8%), including 7 pathogenic and 46 likely pathogenic calls.
- Why it matters: Most KCNH2 findings from genetic testing remain variants of uncertain significance, and translating functional channel effects into actionable clinical evidence is a major bottleneck for LQT2 interpretation.
- What they did: The study used standardized high-throughput automated patch-clamp electrophysiology plus membrane trafficking assays to test 303 KCNH2 variants (201 VUS), then integrated nine electrophysiological parameters with MeTAL and calibrated evidence using ClinGen OddsPath and likelihood-ratio methods.
- The result: Under heterozygous conditions, MeTAL predictions matched patient QTc phenotypes with 82.9% concordance for ACMG class 5 variants, and calibrated likelihood-ratio evidence graded 76.1% of VUS, enabling ACMG/AMP reclassification of 64/201.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.